Bank Julius Baer & Co. Ltd, Zurich Unity Biotechnology, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$5.51 - $9.42 $45,215 - $77,300	-8,206 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$3.42 - $6.36 $225 - $419	66 Added 0.81%	8,206 $43,000
Q4 2020 Feb 12, 2021	BUY	$3.42 - $6.36 $27,838 - $51,770	8,140 New	8,140 $43,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.